Witnessing an explosion of consumer-facing neurotechnologies to (potentially) harness lifelong neuroplasticity

By Apoorv Mathur | January 30, 2017

— Last week I shared some key sci­en­tif­ic, tech­no­log­i­cal and invest­ment trends rev­o­lu­tion­iz­ing Brain Health, based on my par­tic­i­pa­tion at the 2016 Sharp­Brains Vir­tu­al Sum­mit, and promised a sec­ond arti­cle more focused on the tech­nol­o­gy side of things. Here it is :-) Just a few weeks after the Sharp­Brains Sum­mit I also attend­ed CES 2017. While I enjoyed the myr­i­ad emerging…

Read More

Harnessing digital platforms to accelerate R&D and drive proper adoption of cognitive and brain health tools

By SharpBrains | December 26, 2016

Har­ness dig­i­tal plat­forms to accel­er­ate R&D and dri­ve prop­er adop­tion from Sharp­Brains Pio­neers in edu­ca­tion, med­i­cine and phar­ma dis­cussed new data-rich approach­es to help assess what works and what doesn’t, and for whom, accel­er­at­ing R&D ini­tia­tives and prop­er adop­tion cog­ni­tive and brain health tools. Chair: Alvaro Fer­nan­dez, CEO & Edi­­tor-in-Chief of Sharp­Brains Richard Varn, Direc­tor of…

Read More

Sneak preview into the future of mental health: Fully digital clinical trials to study digital therapeutics

By SharpBrains | October 5, 2016

——– Click Ther­a­peu­tics™ Reports Pre­lim­i­nary Results of a 416-Par­tic­i­­pant Clin­i­cal Study Demon­strat­ing Excep­tion­al Engage­ment and Effi­ca­cy of Click­o­tine®, a Patent-Pend­ing Dig­i­tal Ther­a­peu­tics™ Pro­gram for Smok­ing Ces­sa­tion (press release): “Click Ther­a­peu­tics, Inc. (“Click”), a com­pa­ny devel­op­ing a suite of per­son­al­ized data-dri­ven dig­i­tal ther­a­peu­tics for chron­ic health con­di­tions, announces today pre­lim­i­nary results of its ful­ly remote clinical…

Read More

ANNOUNCEMENT: Initial Speakers for 2016 SharpBrains Virtual Summit (Dec. 6–8th) — Reinventing Brain Health in the Digital Age

By SharpBrains | September 14, 2016

We’re thrilled to announce the first round of speak­ers at the upcom­ing 2016 Sharp­Brains Vir­tu­al Sum­mit (Decem­ber 6–8th). More to come…stay tuned! (and reg­is­ter soon to ben­e­fit from ear­­ly-bird rates) We can’t wait to dis­cuss the lat­est work and insights from… Dr. Ali­son Fen­ney, Exec­u­tive Direc­tor of the Neu­rotech­nol­o­gy Indus­try Orga­ni­za­tion Alvaro Fer­nan­dez, CEO of Sharp­Brains Dr. Bob Bilder,…

Read More